Mots-clés
 > MYOBASE > PRODUITS CHIMIQUES ET BIOLOGIQUES > protéine > enzyme > transférase > glycosyltransférase > myophosphorylase
myophosphorylase
Commentaire :
Phosphorylase musculaire, enzyme musculaire de la glycolyse
Sources : Principales maladies neuromusculaires, octobre 2011, Fiche Technique Savoir et Comprendre, AFM Avancées médico-scientifiques neuromusculaires, juin 2011, Fiche Technique Savoir et Comprendre, AFM Synonyme(s)g p ;muscular glycogen phosphorylase ;muscle glycogen phosphorylase ;glycogène phosphorylase musculaire myophosphorylaseVoir aussi |
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology
Migocka-Patrzalek M, Lewicka A, Elias M, et al.
The International Journal of Biochemistry & Cell Biology, 2019, 118
The role of electrodiagnosis with long exercise test in McArdle disease
Semplicini C, Hézode-Arzel M, Laforêt P, et al.
Muscle & Nerve, 2018
Skeletal muscle metabolism during prolonged exercise in Pompe disease
Preisler N, Laforêt P, Madsen KL, et al.
Endocrine connections, 2017, 6, 6, p 384
Neuromuscular disorders of glycogen metabolism
Gazzerro E, Andreu AL
Current neurology and neuroscience reports, 2013, 13, 3, p. 333
Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease
Nogales-Gadea G, Pinos T, Lucia A, et al.
Brain, 2012, 135, 7, p. 2048-2057
Anesthesia considerations in a patient with mcArdle disease: a case report
Choleva AJ
AANA Journal, 2011, 79, 3, p. 243-247
Malignant hyperthermia, coexisting disorders, and enzymopathies : risks and management options
Benca J, Hogan K
Anesthesia and Analgesia, 2009, 109, 4, p. 1049-1053
Révélation d'une maladie de Mc Ardle par une intolérance musculaire à l'effort associée à une rhabdomyolyse sévère
Amezyane T, El Kharras A, Abouzahir A, et al.
Annales d'endocrinologie, 2009, 70, 6, p. 480-484
Permanent muscle weakness in McArdle disease
Nadaj-Pakleza AA, Vincitorio CM, Laforêt P, et al.
Muscle & Nerve, 2009, 40, 3, p 350
Increased PFK activity and GLUT4 protein content in McArdle's disease
Robertshaw HA, Raha S, Kaczor JJ, et al.
Muscle & Nerve, 2008, 37, 4, p. 431-437
McArdle disease : what do neurologists need to know ?
Lucia A, Nogales-Gadea G, Perez M, et al.
Nature clinical practice. Neurology, 2008, 4, 10, p. 568-577
A novel PYGM mutation in a Korean patient with McArdle disease : the role of nonsense-mediated mRNA decay
Sohn EH, Kim HS, Lee AY, et al.
Neuromuscular disorders : NMD, 2008, 18, 11, p. 886-889
Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease : expression and re-expression of glycogen phosphorylase
Howell JM, Walter KR, Davies L, et al.
Neuromuscular disorders : NMD, 2008, 18, 3, p. 248-258
Maladie de McArdle (glycogénose de type V) : étude clinique, biochimique et génétique d'une cohorte de cinq patients français
Delmont E, Sacconi S, Berge-Lefranc JL, et al.
Revue neurologique (Paris), 2008, 164, 11, p. 912-916
Chronic therapy for McArdle disease : the randomized trial with ACE inhibitor
Martinuzzi A, Liava A, Trevisi E, et al.
Acta myologica, 2007, XXVI, 1, p. 64-66
McArdle disease : molecular genetic update
Andreu AL, Nogales-Gadea G, Cassandrini D, et al.
Acta myologica, 2007, XXVI, 1, p. 53-57
Diagnostic tardif d'une maladie de McArdle (glycogénose de type V)
Flavier S, Rolland MO, Eude M, et al.
Annales de biologie clinique, 2007, 65, 5, p. 550-554
McArdle disease with rhabdomyolysis induced by rosuvastatin. Case report
Lorenzoni PJ, Silvado CE, Scola RH, et al.
Arquivos de neuro-psiquiatria, 2007, 65, 3B, p. 834-837
Genotype modulators of clinical severity in McArdle disease
Rubio JC, Gomez-Gallego F, Santiago C, et al.
Neuroscience letters, 2007, 422, 3, p. 217-222
McArdle disease : another systemic low-inflammation disorder ?
Lucia A, Smith L, Naidoo M, et al.
Neuroscience letters, 2007, In advance of print, 2007 Dec 4, 6 p.
McArdle disease presenting as acute renal failure
Pillarisetti J, Ahmed A
Southern medical journal, 2007, 100, 3, p. 313-316
McArdle disease : The mutation spectrum of PYGM in a large Italian cohort
Cassandrini D, Martinuzzi A, Toscano A, et al.
Human mutation, 2006, 27, 7, p. 718
Gentamicin treatment in McArdle disease : failure to correct myophosphorylase deficiency
Schroers A, Kley RA, Stachon A, et al.
Neurology, 2006, 66, 2, p. 285-286
